ClinicalTrials.gg
Sign In
Not yet recruitingNCT06743815Updated Dec 20, 2024

the Percent of AKI Occurred in Patient With Comorbidities Undergoing Colonoscopy

An observational study in Acute Kidney Injuries, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-12-20.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
113
Ages
18 Years to 90 Years
Sex
All
01

Study summary

observation the percent AKI in patient with comorbidities undergoing colonoscopy

Read the detailed description

recording the data of the patient if there are any comorbidities like DM or HTN and observation of the kidney functions before and after the colonoscopy to record the percent of the AKI in patient undergoing colonoscopy

02

Conditions studied

  • Acute Kidney Injuries

Browse trials for

03

In context

Acute Kidney Injury

1,641 studies on the registry are indexed under Acute Kidney Injury; 380 are open to participants now.

This study's planned enrollment of 113 is below the median of 156 across 795 observational studies indexed under Acute Kidney Injury.

Browse Acute Kidney Injury studies →

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Assiut University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

adult patient >18 years old with eGFR.30ml/min

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient aged >18 years old Patient with eGFR>30ml/min

Exclusion criteria

Exclusion Criteria:

  • patient with eGFR \<30ml/min patient with serum electrolytes abnormalities patient with heart diseases (uncontrolled heart failure, unstable angina, myocardial infarction, coronary intervention within the previous 3 months) patients with ascites
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
113 participants (estimated)
Patient registry
No

Groups and cohorts

  • group

    patients subjective for colonoscopy

06

What researchers measure

Primary outcomes

  1. incidence of acute kidney injury

    the incidence of acute kidney injury in patients undergoing colonoscopy

    Time frame: 30 day

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Florentin M, Liamis G, Elisaf MS. Colonoscopy preparation-induced disorders in renal function and electrolytes. World J Gastrointest Pharmacol Ther. 2014 May 6;5(2):50-4. doi: 10.4292/wjgpt.v5.i2.50. PubMed 24868484 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2025; primary completion for Jan 2026, 11 months later.

Of 337 non-industry observational studies under Acute Kidney Injury, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 41. This study's planned 11 months is below that.

Counting every sponsor, half of 350 studies reached it within 24 months; a quarter within 13 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2024
First posted
Dec 20, 2024
StartEst.
Jan 30, 2025
Primary completionEst.
Jan 1, 2026
CompletionEst.
Dec 2027
Last update
Dec 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06743815
Lead sponsor
Assiut University
Responsible party
Mahmoud Abd Elbasset Abd Elmoula Ahmed (resident doctor at Assiut University hospital, Assiut University) — Principal investigator
First posted
Dec 20, 2024
Start date
Jan 30, 2025 (estimated)
Primary completion
Jan 1, 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Dec 20, 2024

Study contacts

Mahmoud abdelbaset Abd El moula, resident doctor
Contact
m.abdelbasset15@gmail.com
+201151392662
AlShaima sayed Hassan, lecturer
Contact
Shaimaa_nephro@aun.edu.eg
+201096883911

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Acute Kidney Injury →

Other studies from this sponsor

Assiut University →

Start the discussion